Literature DB >> 12189179

Factors affecting the direct targeting of murine leukemia virus vectors containing peptide ligands in the envelope protein.

Masumi Katane1, Eiko Takao, Yoshinao Kubo, Rika Fujita, Hiroshi Amanuma.   

Abstract

To develop a reliable strategy for cell-specific delivery of retroviral vectors, we genetically modified the envelope (Env) protein of the ecotropic Moloney murine leukemia virus. We found a site in the variable region A, where the insertion of ligands, epidermal growth factor (EGF) and stromal-derived factor-1 alpha (SDF-1 alpha), was possible without abolishing virion incorporation of the Env protein and its ecotropic entry function. The vector containing the EGF-Env did not show the EGF receptor-dependent transduction. The vector containing the SDF-1 alpha-Env, however, specifically transduced human cells expressing CXCR4, the receptor for SDF-1 alpha, at titers of 10(3)-10(4) c.f.u./ml. Further experiments showed that the CXCR4-dependent transduction was based on the specific interaction between the SDF-1 alpha moiety of the SDF-1 alpha-Env and CXCR4 and was independent of the ecotropic entry function. The direct targeting of the retroviral vector may be possible if the proper chimeric Env structure and the appropriate ligand-receptor system are employed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189179      PMCID: PMC1084232          DOI: 10.1093/embo-reports/kvf179

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  26 in total

Review 1.  Retrovirus receptors.

Authors:  Maja A Sommerfelt
Journal:  J Gen Virol       Date:  1999-12       Impact factor: 3.891

Review 2.  Modifying the host range properties of retroviral vectors.

Authors:  S J Russell; F L Cosset
Journal:  J Gene Med       Date:  1999 Sep-Oct       Impact factor: 4.565

3.  Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

6.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

7.  Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.

Authors:  C A Benedict; R Y Tun; D B Rubinstein; T Guillaume; P M Cannon; W F Anderson
Journal:  Hum Gene Ther       Date:  1999-03-01       Impact factor: 5.695

8.  Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.

Authors:  B W Wu; J Lu; T K Gallaher; W F Anderson; P M Cannon
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

9.  Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.

Authors:  A Yonezawa; T Hori; A Takaori-Kondo; R Morita; T Uchiyama
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

10.  Isolation of recombinant DNA clones carrying complete integrated proviruses of Moloney murine leukemia virus.

Authors:  L Bacheler; H Fan
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  10 in total

1.  Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins.

Authors:  Fang Li; Byoung Y Ryu; Robin L Krueger; Scott A Heldt; Lorraine M Albritton
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 2.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

3.  Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter.

Authors:  M H Verheije; T Würdinger; V W van Beusechem; C A M de Haan; W R Gerritsen; P J M Rottier
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Construction of a gammaretrovirus with a novel tropism and wild-type replication kinetics capable of using human APJ as entry receptor.

Authors:  Shervin Bahrami; Kristina Pagh; Ditte Ejegod; Mogens Duch; Martin Tolstrup; Finn Skou Pedersen
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

Review 5.  Library screening and receptor-directed targeting of gammaretroviral vectors.

Authors:  Peter M Mazari; Monica J Roth
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

6.  Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations.

Authors:  María Mercedes Segura; Alain Garnier; Marcos Rafael Di Falco; Gavin Whissell; Angélica Meneses-Acosta; Normand Arcand; Amine Kamen
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

7.  Directed Molecular Evolution of an Engineered Gammaretroviral Envelope Protein with Dual Receptor Use Shows Stable Maintenance of Both Receptor Specificities.

Authors:  Kristina Pagh Friis; Xavier Iturrioz; Jonas Thomsen; Rodrigo Alvear-Perez; Shervin Bahrami; Catherine Llorens-Cortes; Finn Skou Pedersen
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

8.  Murine leukemia virus (MLV) replication monitored with fluorescent proteins.

Authors:  Katja Sliva; Otto Erlwein; Alexandra Bittner; Barbara S Schnierle
Journal:  Virol J       Date:  2004-12-20       Impact factor: 4.099

9.  Retrovirus entry by endocytosis and cathepsin proteases.

Authors:  Yoshinao Kubo; Hideki Hayashi; Toshifumi Matsuyama; Hironori Sato; Naoki Yamamoto
Journal:  Adv Virol       Date:  2012-12-06

Review 10.  Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines.

Authors:  Cleo Goyvaerts; Karine Breckpot
Journal:  J Immunol Res       Date:  2015-10-25       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.